Does the EUFMD Drive Gray Market Activity? Systech Interview in Supply Chain Digital
The pharmaceutical medicine supply chain has been plagued recently by a number of high-profile incidents involving counterfeit drugs causing deaths across the UK, Ireland and the US. The FMD is legislation passed by the European Union Parliament, which aims to increase the security of the manufacturing and delivery of medicines across Europe and protect patients and prevent falsified medicines from entering the supply chain. As the EUFMD strengthens the supply chain, it may also drive more activity in the Gray Market. Learn more.